$ASMB
Assembly Biosciences Inc

2014 Q1 Form 10-K Financial Statement

#000114420414019383 Filed on March 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2012 Q4 2012 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.140M $1.080M $1.320M
YoY Change -1.72% -20.0% -65.26%
% of Gross Profit
Research & Development $2.974M $2.740M $6.162M
YoY Change 13.97% -84.38% 98.8%
% of Gross Profit
Depreciation & Amortization $1.266K $0.00 $0.00
YoY Change -0.08%
% of Gross Profit
Operating Expenses $2.974M $3.820M $6.162M
YoY Change 13.97% -79.78% 98.8%
Operating Profit -$4.110M -$7.478M
YoY Change 9.05% 8.36%
Interest Expense $40.00K $30.00K $10.00K
YoY Change -20.0% 0.0% -84.83%
% of Operating Profit
Other Income/Expense, Net $40.23K $0.00
YoY Change
Pretax Income -$4.070M -$3.790M -$7.470M
YoY Change 9.41% -79.9% 7.33%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.070M -$3.791M -$7.470M
YoY Change 9.32% -79.9% 7.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$920.8K -$1.463M -$2.953M
COMMON SHARES
Basic Shares Outstanding 23.40M shares 12.49M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2012 Q4 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.60M $20.50M $28.80M
YoY Change -36.04% -44.59% 152.63%
Cash & Equivalents $23.64M $20.49M $28.84M
Short-Term Investments
Other Short-Term Assets $259.2K $59.58K $157.1K
YoY Change 29.6% -4.1% 57.09%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $23.90M $20.55M $29.00M
YoY Change -35.59% -44.52% 152.18%
LONG-TERM ASSETS
Property, Plant & Equipment $8.425K $6.841K $9.375K
YoY Change -16.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $8.425K $6.841K $9.375K
YoY Change -16.76%
TOTAL ASSETS
Total Short-Term Assets $23.90M $20.55M $29.00M
Total Long-Term Assets $8.425K $6.841K $9.375K
Total Assets $23.90M $20.56M $29.01M
YoY Change -35.57% -44.51% 152.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.435M $1.847M $3.158M
YoY Change -4.32% -21.13% 426.31%
Accrued Expenses $27.25K $898.2K $234.0K
YoY Change -93.19% 425.27% 134.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.500M $2.700M $3.392M
YoY Change -25.0% 7.44% 323.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.500M $2.700M $3.392M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.462M $2.745M $3.400M
YoY Change -26.88% 9.82% 61.9%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $23.40K $12.93K $12.92K
YoY Change 4.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.44M $17.81M $25.62M
YoY Change
Total Liabilities & Shareholders Equity $23.90M $20.56M $29.01M
YoY Change -35.57% -44.51% 152.26%

Cashflow Statement

Concept 2014 Q1 2012 Q4 2012 Q2
OPERATING ACTIVITIES
Net Income -$4.070M -$3.791M -$7.470M
YoY Change 9.32% -79.9% 7.3%
Depreciation, Depletion And Amortization $1.266K $0.00 $0.00
YoY Change -0.08%
Cash From Operating Activities -$5.185M -$3.070M -$6.940M
YoY Change 18.65% -81.2% 142.66%
INVESTING ACTIVITIES
Capital Expenditures $2.589K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.589K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.166M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.763M 0.000 4.720M
YoY Change -91.5% -100.0% 2045.45%
NET CHANGE
Cash From Operating Activities -$5.185M -3.070M -6.940M
Cash From Investing Activities -$2.589K 0.000 0.000
Cash From Financing Activities $1.763M 0.000 4.720M
Net Change In Cash -$3.425M -3.070M -2.220M
YoY Change -120.9% -81.18% -15.91%
FREE CASH FLOW
Cash From Operating Activities -$5.185M -$3.070M -$6.940M
Capital Expenditures $2.589K $0.00 $0.00
Free Cash Flow -$5.188M -$3.070M -$6.940M
YoY Change 18.71% -81.2% 142.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74072484 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-24855496 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-19604779 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27061268 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
2831651 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20489219 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-98234586 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1676789 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10448711 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13850826 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-19403759 USD
us-gaap Net Income Loss
NetIncomeLoss
-111723273 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
59584 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
93714274 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23435 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2745458 USD
CY2013 us-gaap Interest Expense Other
InterestExpenseOther
0 USD
us-gaap Interest Expense Other
InterestExpenseOther
4983572 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
65066 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
63672 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
20548803 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
27124940 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6841 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7102 USD
CY2012Q4 us-gaap Assets
Assets
20555644 USD
CY2013Q4 us-gaap Assets
Assets
27132042 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1847245 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2614619 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
898213 USD
CY2013Q4 us-gaap Liabilities
Liabilities
2638054 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
220 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
12934 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
20734 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110116766 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135827557 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
92319514 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
111723273 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
17810186 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
24493988 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20555644 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27132042 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33050 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39266 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12934350 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20733895 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12934350 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20733895 shares
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19514163 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15029078 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5341333 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4575701 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24162102 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
65066 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
201020 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
362139 USD
CY2012 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
CY2013 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
6001496 USD
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2865758 USD
CY2012 us-gaap Interest Expense Other
InterestExpenseOther
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5041953 USD
CY2012 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
CY2012 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2545 USD
CY2013 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4088 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
63672 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
232384 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-107404 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2450518 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21379790 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17796088 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
201020 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-24790430 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.94
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.00
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12726551 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19393486 shares
CY2012 vtus Stock Based Compensation Expense For Services
StockBasedCompensationExpenseForServices
339442 USD
CY2013 vtus Stock Based Compensation Expense For Services
StockBasedCompensationExpenseForServices
36158 USD
vtus Stock Based Compensation Expense For Services
StockBasedCompensationExpenseForServices
4366417 USD
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3466010 USD
CY2012 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2013 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1087876 USD
CY2012 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2013 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
227910 USD
CY2012 us-gaap Depreciation
Depreciation
4618 USD
CY2013 us-gaap Depreciation
Depreciation
6216 USD
us-gaap Depreciation
Depreciation
41839 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79614177 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3241 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6477 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48941 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3241 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6477 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48941 USD
CY2012 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
4166494 USD
CY2013 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
24374614 USD
CY2012 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2013 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1146024 USD
CY2012 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
730322 USD
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1019054 USD
CY2012 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1573000 USD
CY2012 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1573000 USD
CY2012 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2013 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1500000 USD
CY2012 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2013 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1431603 USD
CY2012 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
CY2013 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
419380 USD
CY2012 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2013 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
419380 USD
CY2012 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 USD
CY2013 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 USD
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
800000 USD
CY2012 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 USD
CY2013 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 USD
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
800000 USD
CY2012 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 USD
CY2013 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
4684 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4896816 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24374614 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
106724386 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-16486215 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6572049 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27061268 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36975434 USD
CY2005Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012 vtus Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
0 USD
CY2013 vtus Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
0 USD
vtus Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
341334 USD
CY2012 vtus Warrant Issued In Connection With Convertible Notes
WarrantIssuedInConnectionWithConvertibleNotes
0 USD
CY2013 vtus Warrant Issued In Connection With Convertible Notes
WarrantIssuedInConnectionWithConvertibleNotes
0 USD
vtus Warrant Issued In Connection With Convertible Notes
WarrantIssuedInConnectionWithConvertibleNotes
1166989 USD
CY2012 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
14003158 USD
CY2012 us-gaap Interest Paid
InterestPaid
0 USD
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
685397 USD
CY2008 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
929457 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19204614 USD
CY2011 vtus Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
288732 USD
CY2008 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1803234 USD
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14003158 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
460822 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
123758 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2194535 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2982949 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1308039 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16655 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
6001496 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
164284 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3990817 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
36158 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-8786430 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-13362648 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
11626116 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
34532707 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-4539405 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-15290625 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-34344730 USD
us-gaap Net Income Loss
NetIncomeLoss
-4567894 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
-9457050 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
-4382043 USD
CY2010 vtus Stock Issued During Period Convertible Note Price Per Share New Issues
StockIssuedDuringPeriodConvertibleNotePricePerShareNewIssues
4.20
CY2011 vtus Stock Issued During Period Convertible Note Price Per Share New Issues
StockIssuedDuringPeriodConvertibleNotePricePerShareNewIssues
4.20
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Use of estimates:</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Significant estimates inherent in the preparation of the accompanying financial statements include the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Additionally, the Company provides a valuation allowance for deferred income tax assets when it is considered more likely than not that all or a portion of such deferred income tax assets will not be realized.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
vtus Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
3796 shares
CY2013 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2753126 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3574537 shares
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23792000 USD
CY2008Q3 vtus Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
6151 shares
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
354700 shares
CY2008Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29861 shares
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32193000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5808000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6617000 USD
CY2012Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
5014000 USD
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
6017000 USD
CY2012Q4 vtus Deferred Tax Assets Related Party Interest
DeferredTaxAssetsRelatedPartyInterest
783000 USD
CY2013Q4 vtus Deferred Tax Assets Related Party Interest
DeferredTaxAssetsRelatedPartyInterest
2149000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
35397000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46976000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
35397000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46976000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2005-10-07
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.07 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.11 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.41 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.45 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9132000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
11579000 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0.11 pure
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
67000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2149000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
73000000 USD
CY2012Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4166000 USD
CY2007 vtus Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
12903 shares
CY2012 vtus Warrants Exercised Cashless Feature
WarrantsExercisedCashlessFeature
47550 shares
CY2012 vtus Share Based Compensation Shares Authorized Under Stock Option Plans Grants In Period Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGrantsInPeriodExercisePriceRangeLowerRangeLimit
3.60
CY2013 vtus Share Based Compensation Shares Authorized Under Stock Option Plans Grants In Period Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGrantsInPeriodExercisePriceRangeLowerRangeLimit
2.47
CY2012 vtus Share Based Compensation Shares Authorized Under Stock Option Plans Grants In Period Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGrantsInPeriodExercisePriceRangeUpperRangeLimit
10.62
CY2013 vtus Share Based Compensation Shares Authorized Under Stock Option Plans Grants In Period Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGrantsInPeriodExercisePriceRangeUpperRangeLimit
3.31
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M
CY2012 vtus Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
11620 shares
CY2008Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18977 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2900000 shares
CY2008Q3 vtus Private Placement Financing Per Unit
PrivatePlacementFinancingPerUnit
60.39 USD
CY2011 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
5.77
CY2013 vtus Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
CY2008Q3 vtus Private Placement Financing Per Unit
PrivatePlacementFinancingPerUnit
60.39 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
874651 shares
CY2012 vtus Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
CY2012Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
11.75
CY2008Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
60.39
vtus Percentage Of Warrant Coverage
PercentageOfWarrantCoverage
0.2 pure
CY2008Q3 vtus Percentage Of Warrant Coverage
PercentageOfWarrantCoverage
0.2 pure
invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
66.46
CY2008Q3 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
66.46
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
929457 USD
CY2008Q3 vtus Fair Value Of Warrants Outstanding
FairValueOfWarrantsOutstanding
340860 USD
CY2009Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
4.20
CY2009Q4 vtus Percentage On Public Offering Price
PercentageOnPublicOfferingPrice
0.7 pure
CY2009Q4 vtus Public Offering Price Per Share
PublicOfferingPricePerShare
6.00
CY2010Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
15184344 USD
CY2008 vtus Warrants Forfeited In Period
WarrantsForfeitedInPeriod
1613 shares
CY2010Q4 invest Investment Options Exercise Price
InvestmentOptionsExercisePrice
6.00
CY2012 vtus Warrants Exercise By Cashless Feature
WarrantsExerciseByCashlessFeature
35958 shares
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0389 pure
CY2013 us-gaap Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
1.2818 pure
CY2013 vtus Investment Warrants Term
InvestmentWarrantsTerm
P5Y
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2011Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
956443 shares
CY2012 vtus Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
81792 shares
CY2013 vtus Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
0 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
861046 shares
CY2012Q4 vtus Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
874651 shares
CY2013Q4 vtus Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
861046 shares
CY2011Q4 vtus Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
7.61
CY2012Q4 vtus Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
7.67
CY2012 vtus Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0
CY2013 vtus Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0
CY2012 vtus Class Of Warrant Or Right Expired In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExpiredInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
7.00
CY2013 vtus Class Of Warrant Or Right Expired In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExpiredInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0
CY2013Q4 vtus Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
7.77
CY2012Q4 vtus Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
7.67
CY2013Q4 vtus Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
7.77
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2046455 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1878475 shares
CY2012 vtus Share Based Compensation Arrangement By Share Based Payment Award Option Vested And Expected To Vest Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionVestedAndExpectedToVestGranted
425740 shares
CY2013 vtus Share Based Compensation Arrangement By Share Based Payment Award Option Vested And Expected To Vest Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionVestedAndExpectedToVestGranted
530000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
168240 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
425480 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
69984 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2338491 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1618820 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2322518 shares
CY2012 vtus Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVest
1878475 shares
CY2013 vtus Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVest
2338491 shares
CY2012 vtus Share Based Compensation Arrangement By Share Based Payment Award Options May Be Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMayBeGranted
1920485 shares
CY2013 vtus Share Based Compensation Arrangement By Share Based Payment Award Options May Be Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMayBeGranted
1390485 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.72
CY2013Q4 vtus Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
196419 USD
CY2013Q4 vtus Future Stock Based Compensation Expense Year Four
FutureStockBasedCompensationExpenseYearFour
20239 USD
CY2012 vtus Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestGrantedWeightedAverageExercisePrice
7.64
CY2013 vtus Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestGrantedWeightedAverageExercisePrice
2.88
CY2013Q4 vtus Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
275820 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.40
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.11
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.64
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.60
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.87
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.51
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.31
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0111 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0123 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0132 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0234 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013Q4 vtus Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
1175179 USD
CY2011Q2 vtus Potential Milestone Payments
PotentialMilestonePayments
250000 USD
CY2011Q4 vtus Additional Payments To Acquire Intangible Assets
AdditionalPaymentsToAcquireIntangibleAssets
12500000 USD
CY2007Q1 vtus Percent Of Share Issued On License Agreements
PercentOfShareIssuedOnLicenseAgreements
0.05 pure
CY2007 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.7 pure
CY2010Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5617433 USD
CY2010 us-gaap Debt Conversion Description
DebtConversionDescription
Each 2010 Noteholder holds a warrant to purchase that number of shares of the Company&#8217;s common stock equal to 50% of the principal amount of the 2010 Notes purchased by it divided by the IPO Price at a per share exercise price equal to 110% of the IPO Price, subject to adjustment
CY2010 vtus Debt Instrument Beneficial Convertible Feature And Interrest
DebtInstrumentBeneficialConvertibleFeatureAndInterrest
5398956 USD
CY2009 vtus Percentage Of Warrant On Principal Amount Of Debt Instrument
PercentageOfWarrantOnPrincipalAmountOfDebtInstrument
0.1 pure
CY2009 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
12.40
CY2009Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
341000 USD
CY2010Q1 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
1421834 USD
CY2010Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
1429590 USD
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
VTUS
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23396259 shares
CY2013 dei Entity Registrant Name
EntityRegistrantName
VENTRUS BIOSCIENCES INC
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001426800
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2010 us-gaap Interest Expense Debt
InterestExpenseDebt
3779269 USD
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
46900000 USD
CY2012Q4 vtus Common Stock Value Issuable
CommonStockValueIssuable
0 USD
CY2013Q4 vtus Common Stock Value Issuable
CommonStockValueIssuable
368750 USD
CY2013Q4 vtus Common Stock Issuable Shares
CommonStockIssuableShares
125000 shares
CY2007Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1 pure
CY2013Q4 vtus Future Stock Based Compensation Expense Year One
FutureStockBasedCompensationExpenseYearOne
682701 USD
CY2013 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5170000 USD
CY2013 vtus Share Based Compensation Arrangement By Share Based Payment Award Restricted Value Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedValueGrantedInPeriod
368750 USD
CY2012 vtus Classofwarrantorrightexpiredinperiod
Classofwarrantorrightexpiredinperiod
0 shares
CY2013 vtus Classofwarrantorrightexpiredinperiod
Classofwarrantorrightexpiredinperiod
13605 shares
CY2012 vtus Classofwarrantorrightexpirationsinperiodweightedaverageexercisepriceofwarrantsorrights
Classofwarrantorrightexpirationsinperiodweightedaverageexercisepriceofwarrantsorrights
0
CY2013 vtus Classofwarrantorrightexpirationsinperiodweightedaverageexercisepriceofwarrantsorrights
Classofwarrantorrightexpirationsinperiodweightedaverageexercisepriceofwarrantsorrights
1.24
CY2013Q1 vtus Convertible Preferred Stock Conversion Common Stock Shares Issuable
ConvertiblePreferredStockConversionCommonStockSharesIssuable
2200000 shares
CY2013Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
20800000 USD
CY2013Q3 vtus Common Stock Sales Incremental Value
CommonStockSalesIncrementalValue
20521567 USD
CY2013Q4 vtus Equity Securities Value Available Under Shelf Registration Statement
EquitySecuritiesValueAvailableUnderShelfRegistrationStatement
75000000 USD
CY2013Q4 vtus Payment For Non Refundable License Fee
PaymentForNonRefundableLicenseFee
300000 USD
CY2013 vtus Percentage Of Restricted Stock Units Vested Descriptions
PercentageOfRestrictedStockUnitsVestedDescriptions
The Company valued the restricted stock grant, 75% of which vests in three equal installments when the 20-day trading volume weighted average price of the Companys common stock is at least $4.15, $5.15 and $6.15, using the Monte Carlo simulation model.
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
500000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
125000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
375000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.04
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.27
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.95
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1135000 USD
CY2013 vtus Restricted Stock Expensed Percentage
RestrictedStockExpensedPercentage
0.25 pure

Files In Submission

Name View Source Status
0001144204-14-019383-index-headers.html Edgar Link pending
0001144204-14-019383-index.html Edgar Link pending
0001144204-14-019383.txt Edgar Link pending
0001144204-14-019383-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg49.jpg Edgar Link pending
tpg50.jpg Edgar Link pending
tpg51.jpg Edgar Link pending
tpg52.jpg Edgar Link pending
tpg53.jpg Edgar Link pending
tpg54.jpg Edgar Link pending
tpg55.jpg Edgar Link pending
tpg56.jpg Edgar Link pending
tpg57.jpg Edgar Link pending
tpg58.jpg Edgar Link pending
tpg59.jpg Edgar Link pending
tpg60.jpg Edgar Link pending
tpg61.jpg Edgar Link pending
tpg62.jpg Edgar Link pending
v371774_10k.htm Edgar Link pending
v371774_ex10-22.htm Edgar Link pending
v371774_ex23-1.htm Edgar Link pending
v371774_ex31-1.htm Edgar Link pending
v371774_ex31-2.htm Edgar Link pending
v371774_ex32-1.htm Edgar Link pending
v371774_ex32-2.htm Edgar Link pending
vtus-20131231.xml Edgar Link completed
vtus-20131231.xsd Edgar Link pending
vtus-20131231_cal.xml Edgar Link unprocessable
vtus-20131231_def.xml Edgar Link unprocessable
vtus-20131231_lab.xml Edgar Link unprocessable
vtus-20131231_pre.xml Edgar Link unprocessable